News | December 04, 2009

Image-Guidance Key to Minimally Invasive Oncology Procedures

Local bleeding as the result of an aneurysm rupture can now be visualized by syngo DynaCT in the angio lab. In addition, syngo DynaCT allows you to visualize the ventricular system of the brain to aid in diagnosing pathologic processes.

December 4, 2009 – The World Health Organization (WHO) predicts that cancer will become the world’s most frequent cause of death in 2010, replacing cardiovascular diseases as the most common cause of death. More than 10.6 million people are diagnosed with cancer each year. Of these, 1.3 million are afflicted with lung cancer, 1.2 million with breast cancer, and up to 1 million patients with colorectal tumors. The number of people suffering from cancer is expected to increase by another 50 percent by 2020 (source: WHO 2003).

New, minimally invasive procedures, suitable for the therapy of primary tumors and for metastases, have established themselves in recent years. The new procedures enable targeted tumor treatment via a catheter or a needle, while angiography systems display the position of the device in the patient’s body to the physician. Since therapy takes place locally, impact to the patient is minimalized and quality of life improved as he or she can be released from hospital soon afterward. These local procedures are especially recommended for older patients, who are in poor health, or have a medical condition that does not allow for a major operation or aggressive chemotherapy.

The interventional radiologist (IR) navigates catheters or needles in the millimeter range, using imaging systems and applications throughout the entire process, from tumor evaluation and procedure planning to therapy and follow-up.

To this end, Siemens Healthcare is demonstrating at RSNA 2009 annual conference held November 29-December 4, in Chicago, enhancements to the Artis zee platform, such as tools for improved planning, visualization, and needle guidance, designed to support interventional oncology procedures.

Display soft tissue, including tumors and of the complex structures of the blood vessels, is critical during therapy. syngo DynaCT shortens reconstruction times, enabling clinicians to take abdominal images available to the treating physician within 22 seconds. A study recently conducted at Charité Hospital in Berlin, Germany, showed that syngo DynaCT leads to repositioning of the catheter, and thus increases the reliability of the tumor treatment, in 50 percent of all chemoembolizations1.

A robotic-based angiography system, syngo DynaCT, offers the interventional radiologist greater flexibility and movement. The system’s flat detector rotates 220 degrees twice around the patient, providing cross-sectional images that can cover up to 47 cm. The liver and lungs can also be covered fully.

Advanced planning for embolization of tumor-feeding blood vessels can be done using the syngo Embolization Guidance program. The user can mark the vessel supplying the tumor, and automatically calculate the centerline of the vessel, which is then superimposed on the live fluoroscopic image, to simplify catheter guidance during tumor embolization.

Previously acquired CT, MR or PET/CT images can be fused with high-contrast 3D angiography images by using either the syngo InSpace 3D/3D Fusion solution, or with syngo DynaCT datasets. The fused dataset can be overlayed on live fluoroscopic images in the interventional lab and provides additional information on the tumor during the procedure.

If a tumor is to be treated with an ablative procedure, it is especially important to precisely position the needles that release the energy to the tumor. syngo iGuide helps to plan and position the needle. The iGuide Cappa navigation system supports the placement of radiofrequency and biopsy needles via electromagnetic navigation without requiring any radiation.

[1] Results of a study published in European Radiology March 2009 by Dr. Meyer, University of Berlin, Charite, Germany and Prof. Dr. Wacker; John Hopkins Hospital, Baltimore.

For more information:

Related Content

Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018
News | Pediatric Imaging | July 18, 2018
Fujifilm Medical Systems U.S.A. Inc. announced that it will offer educational opportunities and exhibit its latest...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Points to Need for Performance Standards for EHR Usability and Safety
News | Electronic Medical Records (EMR) | July 18, 2018
A novel new study provides compelling evidence that the design, development and implementation of electronic health...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
Overlay Init